# OnCo record paper-singhi-alk-rearrangements-pancreatic-jnccn-2017 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-singhi-alk-rearrangements-pancreatic-jnccn-2017/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-singhi-alk-rearrangements-pancreatic-jnccn-2017" ;
  schema:name "Identification of targetable ALK rearrangements in pancreatic ductal adenocarcinoma"@en ;
  schema:description "Screening 3,170 pancreatic cancers found five with an ALK gene fusion, all in patients under 50 and none with a KRAS mutation, and three of four treated with ALK inhibitors benefited."@en ;
  schema:url <https://onco.cc/key-papers/paper-singhi-alk-rearrangements-pancreatic-jnccn-2017/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.6004/jnccn.2017.0058>, <https://pubmed.ncbi.nlm.nih.gov/28476735/> ;
  schema:sameAs <https://doi.org/10.6004/jnccn.2017.0058> ;
  schema:datePublished "2017"^^xsd:gYear ;
  schema:author "Singhi AD, Ali SM, Lacy J, et al." ;
  onco:related <https://onco.cc/biomarkers/alk-fusion/> ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/kras-wild-type-pdac/> ;
  onco:targets <https://onco.cc/targets/alk/> ;
  onco:drugs <https://onco.cc/drugs/crizotinib/>, <https://onco.cc/drugs/alectinib/> ;
  onco:institutions <https://onco.cc/institutions/upmc-hillman/> ;
  onco:pathways <https://onco.cc/pathways/rtk-activation/> .